Sutures are a mainstay of almost all surgical fields. Despite an extensive history and widespread use, the universal trend toward simpler, quicker, and more comfortable surgical procedures has fostered the development of sutureless techniques. The first experimentation with fibrin in ocular tissue was in 1978, 1 and the first use of fibrin in human patients was to repair injuries to the lens. 2 These techniques had limited success because of rapid clot lysis by plasmin. With the commercial availability in the last two decades of fibrin adhesives that include the plasmin inhibitor aprotinin, fibrin has seen rapidly growing use in anterior segment surgery.
Fibrin tissue adhesive has been in use for over 25 years for the repair of splenic and liver rupture, and as an adjunct in cardiac surgery. Its 'off-label' use extends to many other abdominal and thoracic procedures, and its derivatives are commonly used in neurological and orthopaedic surgery.
Currently, the most commonly used fibrin-based adhesive in ophthalmology is Tisseel VH Fibrin Sealant (Baxter BioSurgery, Deerfield, Illinois), whose use in ophthalmic applications is considered off-label.
Tisseel consists of two parts that, when mixed, mimic natural clot formation. One part consists of human fibrinogen and bovine aprotinin, whereas the other part consists of human thrombin and calcium chloride.
When the two parts are combined intra-operatively, the final stages of the coagulation cascade are initiated, and a strong, dense, cross-linked fibrin clot forms in about one minute. This clot adheres to rough (but not epithelialized) wound surfaces, and allows the gluing of tissues. Tisseel maintains its adhesive properties for about one week after surgery. The cost of Tisseel from Baxter is about $100 for a 1cc unit dose, making it a more expensive alternative to suture. Many surgeons feel that the savings in surgical time offset this cost, and to reduce this cost some surgeons will use a single unit dose in a sterile fashion for multiple procedures. Because this product requires significant preparation time and is not currently configured for microsurgical use, it has not been used widely in ocular surgery.
Preparation, Handling, and Risks

Pterygium Excision with Conjunctival Autograft
Fibrin adhesive was first popularized in pterygium surgery with conjunctival autografts using a technique described by Koranyi in 2004. 6 In this 
procedure (video available at www.amtsurgery.com), the surgeon removes the pterygium and harvests an autograft in a routine fashion. The autograft is laid stromal-side up on the cornea with its limbus aligned with the limbus of the recipient site. A small drop of thrombin is applied to the dry, bare sclera. Similarly, a small drop of fibrinogen is applied to the stromal side of the autograft. Using forceps, the surgeon inverts the autograft onto the bare sclera site, mixing the two components of the adhesive. The edges of the wound are apposed to the surrounding conjunctival edge by using a 'squeegee' motion with smooth forceps to stretch the graft to fill the bare sclera site. This must be done before the adhesive has polymerized significantly, which takes from 15 seconds to about two minutes, depending on the degree of thrombin dilution used by the surgeon (see above). This technique resulted in significantly less pain than suture, and the average surgery time was cut in half (see Figures 1 and 2) . Others have found that the rate of recurrence in these cases was comparable to suture. In the past, amnion was adhered to the ocular surface exclusively with sutures. However, fibrin adhesive has greatly simplified this procedure by providing rapid adhesion across the entire surface of amnion, rather than just at the edges with sutures. The technique for gluing AMT to the ocular surface depends on the type of amnion used (dry or wet). For more information on surgical technique, contact each product's manufacturer.
Uses in Corneal Surgery
Automated lamellar keratoplasty has been used to treat corneal irregularity caused by previous trauma or surgery. Rather than suture, Kaufman 10 described a technique in which fibrin adhesive was used to secure the graft. This technique involves using a microkeratome to remove the anterior cornea of both the recipient eye and a donor (whole globe or corneoscleral rim mounted on an artificial anterior chamber). The donor lamellar button is placed on the recipient site, and both components of fibrin adhesive are placed in the interlamellar interface.
The excess fibrin adhesive is 'squeegeed' out of the interface with a blunt spatula on the surface of the cornea.
Laser-assisted In Situ Keratomileusis-Epithelial
Ingrowth and Flap Dislocations
Recurrent epithelial ingrowth after laser-assisted in situ keratomileusis (LASIK) surgery is one of the most frustrating complications of this procedure.
Anderson and Hardten 11 first described a technique, which has since been widely used, for placing fibrin adhesive sparingly on the ocular surface to seal the entry portal for epithelial cells that allows this complication. In this application the adhesive is delivered through Baxter's 'duploject' application system, with care taken to deliver equal amounts of each component.
Flap adherence problems (dislocations) in the first 24 hours after LASIK can occur with eye rubbing, tight eyelids, or under dry conditions. In cases of repeated dislocations, fibrin adhesive has been placed in the flap interface with good success. 12 In this method, the edge of about onethird of the flap is reflected centrally onto itself. Less than one drop of thrombin is placed on the exposed stromal bed. This is accomplished by forming a bead of thrombin on the tip of a cannula, then touching that droplet to the stromal surface and using the cannula to spread the droplet over the entire exposed surface. A similar procedure allows placement of less than a drop of fibrinogen on the underside of the reflected flap. The flap is then laid back in place with a 'squeegee' motion to remove excess fibrin material before it polymerizes, and a bandage contact lens is placed. This can be repeated in two or three different meridians. Often it is only necessary to use adhesive under the superior portion of the flap, since downward pressure from the eyelid is the most common cause of these dislocations.
Cataract Surgery
Clear corneal incisions in cataract surgery have become standard practice, but several authors 13 have suggested that post-operative bacterial endophthalmitis is more common among patients having these incisions than those receiving the older scleral tunnel technique. 14 Kim 15 and Henrick 16 have demonstrated that fibrin adhesive showed promise for closure of scleral tunnel cataract incisions, and preliminary evidence on eye bank corneas suggests it may also have value for closing clear corneal incisions with a simple technique using readily available instruments, which may help reduce the risk of infection. 17 Further study on the ideal method for applying adhesive and its possible intraocular toxicity is ongoing. ■ 
About 1mm of limbal tissue is spared and the remaining conjunctiva recedes toward the fornix.
The amnionic membrane is held in place with a thin layer of fibrin adhesive, composed of thrombin and fibrinogen.
